Market Research Blog

With increasing development of the healthcare infrastructure along with probable expenditure of nearly US$ 9.9Trillion in 2019, according to Future Market Insights, production of dental hygiene devices is likely to increase at an exponential rate. As per a latest published report by FMI (Future Market Insights), dental hygiene devices market is likely to grow at a moderate phase of nearly 4.7% in 2019 on a Y-O-Y basis. In addition, FMI also projects that dental hygiene devices market is estimated to surpass market valuation of approximately US$ 3.8Billion in 2019. According to WHO, dental caries are affected by nearly 80% of the adults and children, thereby significantly driving the need for dental hygiene devices.

US To Witness Emergence of New Dental Hygiene Devices Preserving Periosteum

North America is expected to expand at a sluggish rate of nearly 3.8% on a Y-O-Y basis in 2019. However, growing prevalence of the oral diseases and increasing number of skilled dental hygienists across the U.S. is likely to support growth of North America dental hygiene devices market. Recently, US has witnessed the emergence of all-new ultrasonic bone surgery dental hygiene devices, such as Piezotome Cube aiming at making tooth extraction more atraumatic. High-frequency ultrasonic vibration of the dental hygiene devices helps in eliminating need for cutting surgical flap in gingiva, thereby preserving the periosteum.

Potential Opportunities in APAC Spotted

Asia-Pacific is likely to take the lead in dental hygiene devices market in 2019 with India and China contributing on a major basis, with increasing number of cases regarding dental caries. In India, oral and dental health is often neglected by the people. However, with increasing awareness of cosmetic dental treatments and need for enhancing personal esthetics, positive impact is witnessed in the growth and development of APAC dental hygiene devices market. Growing adoption of fresh breath strips and electric toothbrushes further drives the region’s dental hygiene devices market.

Smart Tooth Brushes in the Making

Adoption of innovative dental hygiene devices such as battery and electric-powered tooth brushes especially by the middle and high income groups are expected to drive the dental hygiene devices market at a significant pace. Customized designs for the children and adults are increasingly made available in the global market, thereby driving sales of dental hygiene devices. Pairing toothbrushes with app and other latest technologies is the ongoing trend in the dental hygiene devices market. Brands such as Sonicare and Oral-B are drawing out all stops in the race for being the smartest and best in electric toothbrush sphere, which in turn dives-in possibilities of emergence of new and innovative dental hygiene devices. In addition to this, Colgate also has strived harder to stay in the race of smart toothbrush development with launch of E1 Smart Connect that connects the end-user’s iPhone through Bluetooth.

To gain more insights on developments in dental hygiene devices market, click here.

A senior analyst discusses on how innovative animal healthcare programs are benefiting the overall animal healthcare landscape.

Demand for high-protein diets has led to commercial farming of the meat and milch cattle. In developed regions such as North America, governments are taking active initiatives in controlling and preventing animal diseases, thereby, creating advisory systems for raising awareness in the general population regarding animal healthcare. Several pharmaceutical companies are increasing their focus towards animal healthcare market, catering to the surging incidences of animal disease outbreaks and hygiene management products.

How are animal healthcare programs beneficial?

On a broader perspective, with the latest animal healthcare program, an initiative by Madhya Pradesh (MP’s) Animal Husbandry Department, signing a MoU (memorandum of understanding) with BFIL (Bharat Financial Inclusion Ltd), the animal owners could avail wide-ranging veterinary services by just dialing toll-free helpline number- 1962. This animal healthcare program is likely to help the farmers, who face major issues in bringing their cattle to the animal healthcare centers.

What are some of the most recent developments in the global animal healthcare market?

Robinson Animal Healthcare, manufacturer of animal’s first-aid woundcare as well as absorbents launched an all-new Animalintex Hoof Treatment, highly beneficial in rapid treatment of the foot conditions. This new animal healthcare product is the sole VMD (Veterinary Medicines Directorate) licensed product in UK consisting of multi-layered absorbent poultice.

Colorado State University introduced a new certificate, known as Spanish for Animal Health and Care for ensuring students in animal science and veterinary fields would be equipped for communicating with the Spanish speakers in a ranch setting.

How is the trend of pet ownership taking a major leap in North America animal healthcare market?

Most of the people in U.S. own a cat or dog, which in turn increases animal expenditure especially by the millennials that are driving humanization of their furry companions. Animal healthcare is one of the most innovative and developing industries of the U.S. Animal healthcare products helps in enhancing activities in pet services, dairy and meat production, animal production and veterinary services. In addition, animal healthcare market in North America has witnessed some major M&A for attaining expertise in launching new and innovative active pharmaceutical ingredients. For example, Zoetis lately acquired Nexvet, biologic therapeutics company for introducing monoclonal antibody therapies, benefitting companion animals suffering from chronic pain.

What are some of the market strategies adopted by key companies in the animal healthcare market?

Animal healthcare manufacturers such as Neogen Corporation are taking immense efforts in acquiring animal genomics laboratory such as the one Delta Genomics Centre owns in Canada. Such acquisitions are done for enhancement of business in the particular region. Several manufacturers such as Henry Schein are planning on merging with animal healthcare businesses and start-ups, in a bid to form new companies.

In a nutshell, with increasing number of pet owners willing to make heavy payments for veterinary care, upsurge in demand for the food supplements is likely to increase at a significant rate in the animal healthcare market.

To get more Insights? Then request a free sample report.

A new device developed by University of California Berkeley, can be potentially used for absorbing excess chemotherapy drugs before they circulate in the bloodstream. This has shown potential to significantly reduce side effects of the chemo drugs for patients undergoing the treatment.

Chemotherapy is a part of the standard treatment procedure for diagnosed cancers. While it attacks the tumor and stops its further growth, but it also causes a great collateral damage to healthy tissues in the body as well. Oncologists and radiologists agree that chemotherapy is not exactly the most effective therapy in cancer treatment but lack of alternatives has made it the only viable option right now. Chemotherapy is riddled with massive side effects including anaemia, dysfunctional immune system, hair loss, nausea and vomiting. Although it manages to kill cancerous cells but studies have suggested that 50-80 % of chemo drugs don’t even reach the tumor and instead circulates in the bloodstream causing damage to healthy cells.

The new device developed by a team of researchers at UC Berkeley, will act as ‘sponge’ which will absorb excess chemo drugs from the bloodstream. Professor Nitash Balsara, the head of UCB’s team, said that the device is inspired by absorbers used in petroleum refining, which regularly uses absorbers to remove unwanted chemicals like sulphur. The team created 3D printed tiny cylinders, 3mm long made from poly diacrylate (ethylene glycol), with a square lattice structure inside which allows blood vessels to pass through it. But the lattice structure is coated with copolymer which attaches itself to the chemo dug and stops its passage. The device shows promises to bring down side effects of chemotherapy and opens doors for increased chemo dosage for the patients in need of it.

Doxorubicin, with brand name Adriamycin is a chemotherapy drug used for many types of cancer. The team used this drug for testing on three pigs and found that when the drug was injected in a particular vein, it flew through the bloodstream and was detected by the device. 64% of the drug was captured by the device. Prof. Balsara said that the team considered all the risk factors like thrombosis or blood clotting while developing the device and issues related to vein wall dissection and blood clots were not observed.

Cancer researchers have long been looking for good alternatives for chemotherapy, while some breakthroughs in targeted medicine which selectively kills only cancerous cells excluding the healthy ones has made much headway. But chemotherapy is going to hang around for a while. The new device offers hope for 650,000 cancer patients in USA and millions worldwide who undergo chemotherapy every year. Although much work remains to be done before the device’s roll out in hospitals the study has shown hope to reduce side effects of drugs and scope for regionally targeted high dose chemotherapy.

In a new study, researchers at Washington University School of Medicine in St. Louis may have uncovered important explanation on how and why poor sleep is linked to early signs of Alzheimer’s disease.

Older people who have reduced slow-wave sleep – the deep sleep required to accumulate memories and wake up feeling refreshed – tend to have higher percentage of the brain protein tau, according to the researchers. Elevated tau has not only been associated with memory loss, confusion, and brain damage but also been considered as a sign of Alzheimer’s disease.

Findings of the study, appeared recently in Science Transitional Medicine, suggest that poor-quality sleep in later life could a warning sign of deteriorating brain health.

Most interestingly, the team observed an inverse relationship between reduced slow-wave sleep and increased tau protein in people who were cognitively normal or mildly impaired, indicating that decreased slow-wave sleep could be a marker for the transition from normal cognition to impaired one.

According to Brendan Lucey, MD, first author and assistant professor of neurology, measuring the way people sleep would be a noninvasive method to check for Alzheimer’s disease before and as the people start to have issues with memory and thinking.

Changes in the brain that lead to Alzheimer’s disease, affecting an estimated 5.7 million US population, begin slowly and silently. Up to two decades, amyloid beta proteins begin to consolidate into plaques in the brain, before the distinctive symptoms of confusion and memory loss appear. Tau proteins tangled up much later, followed by deterioration of key brain regions. Only then do people start showing the critical symptoms of cognitive decline.

It has been a challenge detect people who are likely to develop Alzheimer’s, prior to changes in the brain that limits the ability to think clearly.

For better understanding of the relationship between sleep and Alzheimer’s disease, the team examined 119 study participants 60 years of age or above. Of which, around 80% were cognitively normal, while the remaining ones were very mildly impaired.

The researchers monitored the volunteers’ sleep at home over the course of a normal week. To measure the brain waves, the participants were provided a portable EEG monitor strapped on their foreheads and for wristwatch-like sensor for tracking the body movement. Additionally, they kept a sleep log, noting down nighttime sleep sessions as well as daytime napping.

The researchers also measured levels of tau protein and amyloid beta in the brain and in the cerebrospinal fluid. Of all the participants, 38 underwent brain PET scan for the two proteins, 104 underwent spinal taps, and 27 did both.

After controlling for different factors such as age, sex, and sleep movements, the researchers discovered that reduced slow-wave sleep associated with elevated tau in the brain and a high ratio of tau-to-amyloid in the cerebrospinal fluid.

Lucey said that the important observation is that the total amount of sleep was not linked to tau, but rather the slow-wave sleep, reflecting the quality of sleep. If future research confirms their results, sleep monitoring may contribute as a simple and affordable way to screen earlier of Alzheimer’s disease, the researchers said.